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The immunodeficiency state in HIV infected patients
has been the cause of severe episodes of Recurrent
Aphthous Stomatitis (RAS). Aim: Our study aims to establish
correlation between the manifestations of RAS and the
immunosuppression state caused by HIV infection, through
counting of CD4+ cells, CD8+ cells, CD4+:CD8+ cells ratio
and viral load. Study design: series study. Material and
Method: Ninety-four HIV infected patients (25 women
and 69 men) with RAS were evaluated in the ENT
Department of the University of Sao Paulo-Medical School
from January 1998 to December 2003. The age ranged
between 19 and 63 years (mean = 35.3 years). The patients
were divided in two groups: AIDS group and HIV infected
group. Results: The patients with AIDS and HIV infection
presented, respectively, eight ulcers and two ulcers by
outbreaks. Similarly, patients with major RAS presented
smaller counting of cells CD8+, CD4+ and CD4+/CD8+
cells, and higher mean value of viral load than the patients
with herpetiform and minor RAS. Between patients with
minor and herpetiform RAS there were no statistical
differences. Conclusions: The emergence of the lesions,
mainly in major RAS, is directly related to the immunological
state of the HIV infected patient. These patients frequently
present nutritional deficits and worsening in life style. Thus,
diagnosis and treatment of RAS is a challenge that should
not be neglected.
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INTRODUCTION
Recurrent Aphthous Stomatitis (RAS) is a disorder
characterized by painful ulcers with variable size and duration
typically found in nonkeratinized sites of the oral mucosa.
The three major types of aphtous stomatitis are minor, ma-
jor and herpetiform. They are differentiated by number, size
and duration, however such differentiation is not always
clear1,2.
In general, minor type aphtous stomatitis measures
less than 10mm and lasts on average from 10 to 14 days
and is more common than the others. The major type
Aphthous stomatitis (ulcers size ranging from 10-30mm) is
less common and more severe, lasts longer (weeks and
months), and usually results in scars.
The herpetiform types of ulcers (1 to 3mm size) are
less frequent2,3 and the number of ulcers can be highly
increased up to 100 ulcers per episode. Its name derives
from its alleged similarity with oral ulcers caused by primary
herpetic gingivostomatitis, but Herpes Simplex Virus (HSV)
could not be isolated in the ulcers.
Severe episodes of RAS have been reported in
patients with human immunodeficiency virus (HIV) 2, 4, 5.
Typically the ulcers have three types and are commonly
located in the soft palate, tonsillar sites or tongue. Although
many of such patients referred RAS in childhood, its
frequency decreased with age and became more severe
after symptomatic HIV infection. Most of the infected
patients did not remember having any episode of RAS before
acquiring HIV. Abnormalities in lymphocyte population of
such patients have been considered as the etiological
hypothesis for such lesions6, 7, but there are no available
studies relating the disease to patient’s viral load.
The objective of this study was to establish evidences
between the onset (or increase in severity) of RAS related
to HIV immunosuppresion through CD4+, CD8+ cell count
and viral load, and to relate the type of lesion found to
immune status of the patient.
MATERIAL AND METHODS
A consecutive group of 94 positive HIV patients
(1) (25 female and 69 male), with major, minor and
herpetiform RAS were followed up in the AIDS Outpatient
Unit of the Clinical ENT Department of Hospital das Clíni-
cas - FMUSP from January 1998 through December 2003.
Patients’ ages ranged from 19 to 63 years (mean age=
35.3 years).
Direct Immunofluorescence tests were performed in
skin swab using direct Syva MicroTrak HSV-1/HSV-2 (Syva
Co., Palo Alto, Calif.) to rule out the etiological causes of
ulcers related to herpes virus (HSV) and neutropenia as
recommended by MacPhail et al. (1991), followed by com-
plete blood test.
Blood samples were collected for CD4+, CD8+ cells
count and viral load in the first appointment and subsequent
follow up visit.
Twenty patients were excluded from the study (8
female and 12 male) since they had neutrophil and blood
count below the normal values (1800 to 6800/mm3)/, and
other 12 patients (3 female and 9 male) that tested positive
for HSV in direct identification test.
All the remaining patients (62 patients) tested positive
for HIV were evaluated at least twice a week within an
interval of 30 days between each appointment. During the
first appointment patients answered a questionnaire in order
to record a thorough history of oral and past systemic diseases,
including drugs currently in use. The questionnaire also
included presence or absence of RAS in childhood and
teenage years and if the answer was affirmative, patients
should inform its characteristics related to number, frequency,
duration, size, location and painful symptoms associated with
it.
Patients underwent a thorough ENT examination. The
presence of any oral disease was recorded, including the
number, size, location and duration of current apthae.
The ulcers were classified as minor, major or
herpetiform based on its size and amount per episode.
Biopsy was performed in oral ulcers with a punch
higher than 6mm. The collected sample was formalin-fixed
(10% formalin) and stained in hematoxillin and eosin and
examined under optical microscopy.
First, the patients were divided into two groups. The
first group with 35 patients met the criteria of the Center for
Disease Control in Atlanta (CDC - 93) for acquired
immunodeficiency syndrome (AIDS). The second group with
27 patients was formed by HIV positive cases.
In each one of the two groups (Aids and HIV-positive)
the predominant type of ulcer was recorded, including the
number of ulcers per episode. Results were expressed in
percentage and submitted to statistical analysis applying
Student’s T-test.
Subsequently, patients were divided in three new
groups according to the type of ulcer they had (major, minor
or herpetiform). Mean values of CD4+, CD8+ cell counts and
viral load in each sub-group were statistically compared
applying the Student’s T-test.
RESULTS
The number of patients per type of aphtous ulcer, as
well as the mean CD4+, CD8+ cell count and mean CD4+/
CD8+: viral load ratio are listed in Table 1.
All types of ulcers were found in this study as follows:
29.03% of patients with isolated major type ulcers, 40.32%
with minor type ulcer, and 16.2% with herpetiform type.
The remaining patients (9/62) had different types of apthae
in different appointments or in the same appointment.
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All pathophysiological analysis detected only the
presence of ulcerative lesion in oral mucosa followed by
inflammatory infiltrate in the sub mucosa.
Patients with major and herpetiform type ulcers had
never had the lesion before. – 54.83% of patients (34/62)
did not remember having RAS in childhood. The remaining
patients (28/62, 45.16%) reported RAS in childhood
characterizing apthae as minor.
Patients with Acquired Immunodeficiency Syndrome
(Aids) (CDC-93) had three types of oral ulcers. In each group,
it accounted for less than half of the patients. There was not
a most common type of aphtous ulcer found between
patients with Aids and HIV-positive.
However, patients with Aids had an increased number
of apthae per episode against those patients only HIV-
positive disease. The mean number of apthae per episode
in patients with Aids was eight (8), whereas in HIV-positive
patients it was two (2). The difference was statistically
significant (p=0.002).
Lymphocyte T CD4+ count showed a statistically
significant relation with the RAS type. Patients with major
type apthae compared against patients with minor type
lesions had lower CD4+ cell count than those patients with
herpetiform apthae (p=0.002) and patients with minor
apthae (p=0.001).
On the other hand, the comparison between patients
with herpetiform and minor ulcers did not show statistically
significant difference in CD4+ cell count (p=0.053).
Likewise, patients with major apthae presented lower
CD8+ cell count if compared against patients with herpetiform
apthae (p=0.002) and minor apthae (p=0.001). There was
no statistically significant difference between patients with
herpetiform and minor apthae (p=0.006).
As regards to CD4+/CD8+ ratio, patients with major
apthae had a lower mean against those patients with minor
and herpetiform apthae. This difference, however, was not
statistically significant. There was no statistically significant
difference related to CD4+ or CD4+/CD8+ ratio in patients
with herpetiform and minor apthae.
With respect to absolute CD4+ cell count, 55.5% (10/
18) of the patients with major type apthae had less than 60
cells/mm3, against only 20% of the patients with herpetiform
and minor apthae (7/35) that had cell count below 60 cells/
mm3. This difference was statistically significant (p=0.002).
The onset of major ulcers, if compared with the onset
of minor or herpetiform ulcers, was also associated with a
higher mean value of viral load. This difference was
statistically significant (p=0.002).
The comparison of patients with minor and
herpetiform apthae against the mean viral load was not
statistically different (p=0.056).
DISCUSSION
Three types of apthae were found in the studied
population. Total number of patients that presented major
and herpetiform type were 45.5%. This finding was slightly
different from that of MacPhail et al.2, which reported 66%
of the HIV patients with major and herpetiform aphtous
ulcers.
The results of this study were also different from those
of other research studies carried out related to the same
topic in non-HIV patients, which estimated incidence level
of 80% of minor type apthae and 20% of major and
herpetiform type apthae8,9.
However, there is an increased likelihood that the
cause of such incidence of major and herpetiform type
aphtous ulcer could be related to HIV infection itself and
the subsequent immunosuppression of our patients, since
none of them remembered having ulcers of such type during
childhood.
The association of major apthae with immunosuppression
degree becomes clearer whenever those patients with this
type of aphtous ulcer have lower CD4+ and CD8+ cell count
Table 1. Correlation between types of apthae, number of patients, lymphocyte and viral load count in HIV patients.
Type of apthae Total number Number of Number of CD4 CD8 CD4/CD8 Viral
of patients patients positive (mean) (mean) (mean) Load (mean)
with AIDS HIV patients
Major 18 6 12 123 610 0,29 163420
(15-367) (32-4204) (66322-356731)
Minor 25 10 15 346 948 0,3 18744
(41-932) (208-2324) (2610-82244)
Herpetiform 10 3 7 295 826 0,4 23869
(22-645) (86-1867) (4260-136254)
Mixed 9 2 7 327 812 0,35 20456
(12-544) (301-2103) (3008-124749)
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and increased inversion in the CD4+/CD8+ ratio against those
patients with minor and herpetiform aphtous ulcer.
Interestingly enough, the number of patients with
major apthae and total CD4+ cell count below de 60 was
higher in those patients with herpetiform and minor apthae.
Some authors believe that RAS represents a local
defect in immunomodulation with abnormalities in
lymphocyte population (both blood stream and aphtous ulcer
lymphocytes) resulting in a T CD8+ cell “attack” and
subsequent destruction of the epithelium 10-12.
Since HIV infection is characterized by a progressive
decline of CD4+ cell count and inverted CD4+/CD8+ ratio
such as “relative increase” of CD8+ cells (mainly in ulcerative
stage) it would result in a local defect amplification in the
immunoregulation13.
Another interesting aspect is that although no
prevalence of any type of apthae was found between any
patient with AIDS and HIV- positive, the number of lesions
per episode was higher in patients with Aids than in those
patients with HIV positive, which may be an indicator of
the correlation between immunosuppressant and increased
severity of RAS.
Finally, it is important to point out that in this study
the patients with major type apthae presented an increased
mean of viral load against those patients with herpetiform
and minor apthae. The authors do not know so far any other
study in the literature that related viral load to the type of
apthae found in patients. In our opinion viral load in patients
with major aphtous ulcers could be directly related to
accelerated decrease of CD4+ cells and inversion of the nor-
mal CD4+/CD8+ ration resulting in the onset of more severe
lesions.
All patients in this study were treated with thalidomide
(200mg/day) or dapsone (100mg/day) plus topical steroid
drug (triancinolone in orabase ointment). In more severe
cases the drug chosen was prednisone (60mg/day) per week
until complete regression of lesions13.
CONCLUSION
RAS-related morbidity is significant. The onset of
lesions, primarily the major apthae, is directly related to the
immune status of the HIV patient. These lesions result in
inadequate eating and speaking for the patients, leading to
nutritional deficits and worsening the quality of life. Since
new anti-retroviral drugs have been prolonging survival rate,
the patients with RAS diagnosis should not be neglected
and treatment still remains a challenge even in relative states
of immunosuppresion.
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